#News｜MPP launches an ambitious 3⃣-year #strategy for greater #access2Meds & #health technologies for those in need. Read our statement👉🏽bit.ly/3DqpH6s Access our strategy👉🏽bit.ly/3WRVBj0 Unitaid Swiss Development and Cooperation France Diplomacy 🇫🇷🇪🇺 GIZ MOFA of Japan

#HappeningNow｜World Health Organization (WHO) ED Tedros Adhanom Ghebreyesus is opening MPP's strategy launch, delivering a video message. youtu.be/qG2mQLcYnzk #PublicHealth #GlobalHealth #HealthForAll

🎙️Desmond Tutu Health Foundation's Nombeko Mpongo highlights the importance of long-acting tech that can offer innovative ways to administer drugs that require less frequent dosing, potentially simplifying treatment & prevention. > This is part of Goal 3 of MPP's #strategy. bit.ly/3WRVBj0

🗣️ We #JustLaunched our Community Advisory Panel (CAP)‼️ ⏳The CAP is a new mechanism that serves a key advisory role in providing MPP and our Expert Advisory Group with critical insights and guidance from its members’ expertise and lived experiences. 👉🏽bit.ly/3THzTys

📢Watch this space!📢 We will be announcing the #INTEREST2023 speakers very soon! Dont forget to register! You won't want to miss INTEREST this year!

Congratulations Dr. Ngamije Daniel who.int/news/item/23-0….

📢 SPEAKER ANNOUNCEMENT! Dr. Tiwadayo Braimoh (Tiwadayo Braimoh) of the Medicines Patent Pool (MedicinesPatentPool) will be at #INTEREST2023 discussing #AccessToMedcine. AIGHD Academic Medical Education

Delighted to be in Cape Town, 🇿🇦 to support a sustainable model for mRNA technology transfer to give low- & middle-income countries equitable access to lifesaving health products: bit.ly/43Ry8TN Proud of such initiatives with lasting impact for generations ahead. #WHO75

We welcome the G7 Italy Nagasaki Health Ministers’ Communiqué published recently & the highlight of MPP's voluntary licensing mechanism as a an important tool to improve equitable access to #vaccines and other #medical products. #G7HiroshimaSummit

Yesterday, MedicinesPatentPool & @Unitaid held their 1⃣st #business briefing in #Japan🇯🇵 on how voluntary licensing & global access strategies could work in harmony with, and provide material benefit, to #pharma companies, while supporting global access to life-saving treatments.

This side event will play a crucial role in advancing the cause of the African Medicines Agency (AMA) and its operationalisation within the continent. Join us in Lusaka, Zambia, around the time of the 3rd #CPHIA2023 Conference. Register: bit.ly/3SFuvx1

Tiwadayo Braimoh, MedicinesPatentPool Policy & Advocacy Manager talked through what a fully operational AMA could mean for access to the affordable versions of innovative medicines. #CPHIA2023

Abstract co-submissions to #INTEREST2024 and AIDS2024 IAS - the International AIDS Society have been approved! Know more about co-submissions on our website: interestworkshop.org/abstracts/. Good news, you can submit abstracts in either English or French. Join us at INTEREST 2024! #HIVAIDS #AIDS2024 #Cotonou

📢Today at #EB154, Tiwadayo Braimoh delivered a statement on behalf of MPP, under Pillar 2: One billion more 👥people better protected from #health emergencies. Read statement delivered here👇🏽 bit.ly/3HyelPu

Yesterday, Tiwadayo Braimoh of MPP participated at #G20Brazil 🇧🇷and delivered a statement at the 2nd G20 Brasil Health Working Group meeting in #Brasilia👇🏾 ✅MPP welcomes the proposal to create a “global alliance for local and regional production🏭 and innovation👩🏾‍🔬”. ✅MPP is

With 20 years of work in increasing #access to #medicine, Tiwadayo Braimoh from MedicinesPatentPool helps reshape global policy surrounding #intellectual #property #licensing and #technology #transfer. Discuss with people like Tiwadayo at #INTEREST2024: Register:virology.eventsair.com/interest-2024/…

⁦INTEREST Conference⁩ presentation by ⁦Tiwadayo Braimoh⁩ of ⁦MedicinesPatentPool⁩ in Benin on bending the envelope for #antiretroviral access to 24 million Travel with HIV before #patent expiration. 👍👍👍

"1 billion packs of #dolutegravir formulations have reached 24M people in 128 countries as result of collaborative efforts between the Medicine Patents Pool and innovators," MedicinesPatentPool, Switzerland.

In our paper just published, we share reflections on what would be needed to achieve rapid access to therapeutics in LMIC, upon the declaration of a public health emergency. Please, read here: …balizationandhealth.biomedcentral.com/articles/10.11…

#Publication📰 | Our latest article "Intellectual Property Licensing of Therapeutics During the #COVID19 Crisis: Lessons Learnt for #PandemicPreparedness and Response" published in Globalization and Health is out! This paper highlights the role of voluntary licensing in facilitating access to